Dupilumab Treatment Efficacy and Impact on Clinical Scores, Serum Biomarkers, and Itch in Adult Patients with Atopic Dermatitis: A Retrospective Analysis

References

• Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66(Suppl. 1):8–16. doi:10.1159/000370220
   PubMed Web of Science ®Google Scholar
• Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: part 1: diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338. doi:10.1016/j.jaad.2013.10.010
   PubMed Web of Science ®Google Scholar
• Chopra R, Silverberg JI. Assessing the severity of atopic dermatitis in clinical trials and practice. Clin Dermatol. 2018;36(5):606–615. doi:10.1016/j.clindermatol.2018.05.012
   PubMed Web of Science ®Google Scholar
• Kato A, Kamata M, Ito M, et al. Higher baseline serum lactate dehydrogenase level is associated with poor effectiveness of dupilumab in the long term in patients with atopic dermatitis. J Dermatol. 2020;47(9):1013–1019. doi:10.1111/1346-8138.15464
   PubMed Web of Science ®Google Scholar
• Wu KG, Li TH, Chen CJ, Cheng HI, Wang TY. Correlations of serum interleukin-16, total ige, eosinophil cationic protein and total eosinophil counts with disease activity in children with atopic dermatitis. Int J Immunopathol Pharmacol. 2011;24(1):15–23. doi:10.1177/039463201102400103
   PubMed Web of Science ®Google Scholar
• Dhar S, Malakar R, Chattopadhyay S, Dhar S, Banerjee R, Ghosh A. Correlation of the severity of atopic dermatitis with absolute eosinophil counts in peripheral blood and serum ige levels. Indian J Dermatol Venereol Leprol. 2005;71(4):246–249. doi:10.4103/0378-6323.16615
   PubMedGoogle Scholar
• Avena-Woods C. Overview of atopic dermatitis. Am J Manag Care. 2017;23(8 Suppl):S115–S123.
   PubMed Web of Science ®Google Scholar
• Gelmetti C, Girolomoni G, Patrizi A. Critical review of guidelines and practical recommendations for the management of patients with atopic dermatitis. Dermatite Atopica 2016–2017 SIDeMaST; 2016. Available from: www.aidro.org. Accessed April 12, 2023.
   Google Scholar
• Wollenberg A, Thomsen SF, Lacour JP, Jaumont X, Lazarewicz S. Targeting immunoglobulin E in atopic dermatitis: a review of the existing evidence. World Allergy Organ J. 2021;14(3):100519. doi:10.1016/j.waojou.2021.100519
   PubMed Web of Science ®Google Scholar
• Mogensen TH. Primary immunodeficiencies with elevated ige. Int Rev Immunol. 2016;35(1):39–56. doi:10.3109/08830185.2015.1027820
   PubMed Web of Science ®Google Scholar
• Wollenberg A, Blauvelt A, Guttman-Yassky E, et al. Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled Phase III trials (ECZTRA 1 and ECZTRA 2). Br J Dermatol. 2021;184(3):437–449. doi:10.1111/bjd.19574
   PubMed Web of Science ®Google Scholar
• Deleuran M, Thaçi D, Beck LA, et al. Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a Phase 3 open-label extension study. J Am Acad Dermatol. 2020;82(2):377–388. doi:10.1016/j.jaad.2019.07.074
   PubMed Web of Science ®Google Scholar
• Silvestre Salvador JF, Romero-Pérez D, Encabo-Durán B. Atopic dermatitis in adults: a diagnostic challenge. J Investig Allergol Clin Immunol. 2017;27(2):78–88. doi:10.18176/jiaci.0138
   PubMed Web of Science ®Google Scholar
• Wechsler ME, Klion AD, Paggiaro P, et al. Effect of dupilumab on blood eosinophil counts in patients with asthma, chronic rhinosinusitis with nasal polyps, atopic dermatitis, or eosinophilic esophagitis. J Allergy Clin Immunol Pract. 2022;10(10):2695–2709. doi:10.1016/j.jaip.2022.05.019
   PubMed Web of Science ®Google Scholar
• Italian Medical Agency (AIFA, Agenzia Italiana Farmaco). Dupilumab: assessment of innovativeness. WWW document; 2020. Available from: https://www.aifa.gov.it/documents/20142/1308577/97_Dupixent_14869_scheda_innovativita_GRADE.pdf. Accessed April 12, 2023.
   Google Scholar
• de Bruin-Weller M, Thaçi D, Smith CH, et al. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ). Br J Dermatol. 2018;178(5):1083–1101. doi:10.1111/bjd.16156
   PubMed Web of Science ®Google Scholar
• Forkasiewicz A, Dorociak M, Stach K, Szelachowski P, Tabola R, Augoff K. The usefulness of lactate dehydrogenase measurements in current oncological practice. Cell Mol Biol Lett. 2020;25(1). doi:10.1186/s11658-020-00228-7
   PubMed Web of Science ®Google Scholar
• Thijs J, Krastev T, Weidinger S, et al. Biomarkers for atopic dermatitis: a systematic review and meta-analysis. Curr Opin Allergy Clin Immunol. 2015;15(5):453–460. doi:10.1097/ACI.0000000000000198
   PubMed Web of Science ®Google Scholar
• Kogawa K, Minakawa S, Matsuzaki Y, et al. Correlation between lactate dehydrogenase and other laboratory data in patients with atopic dermatitis. J Cutan Immunol Allergy. 2022;5(4):133–135. doi:10.1002/cia2.12225
   Google Scholar
• Holm JG, Agner T, Clausen ML, Thomsen SF. Determinants of disease severity among patients with atopic dermatitis: association with components of the atopic march. Arch Dermatol Res. 2019;311(3):173–182. doi:10.1007/s00403-019-01895-z
   PubMed Web of Science ®Google Scholar
• Stone SP. Atopic dermatitis and ige. relationship between changes in ige levels and severity of disease. Arch Dermatol. 1976;112(9):1254–1255. doi:10.1001/archderm.1976.01630330024005
   PubMedGoogle Scholar
• Laske N, Niggemann B. Does the severity of atopic dermatitis correlate with serum IgE levels? Pediatr Allergy Immunol. 2004;15(1):86–88. doi:10.1046/j.0905-6157.2003.00106.x
   PubMed Web of Science ®Google Scholar
• Joishy M, Alfaham M, Tuthill D. Does the severity of atopic dermatitis correlate with serum IgE levels? Pediatr Allergy Immunol. 2005;16(3):283. doi:10.1111/j.1399-3038.2005.00212.x
   PubMed Web of Science ®Google Scholar
• Renert-Yuval Y, Del Duca E, Pavel AB, et al. The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults. J Allergy Clin Immunol. 2021;148(1):148–163. doi:10.1016/j.jaci.2021.01.001
   PubMed Web of Science ®Google Scholar
• Askin O, Yucesoy SN, Serdaroglu S. The evaluation of dupilumab treatment response in atopic dermatitis patients. North Clin Istanbul. 2020;8:2.
   Web of Science ®Google Scholar
• Mizuno M, Horiguchi G, Teramukai S, et al. Association study of transition of laboratory marker levels and transition of disease activity of atopic dermatitis patients treated with dupilumab. Australas J Dermatol. 2021;62(4):e504–e509. doi:10.1111/ajd.13719
   PubMed Web of Science ®Google Scholar
• Renert-Yuval Y, Thyssen JP, Bissonnette R, et al. Biomarkers in atopic dermatitis-A review on behalf of the international eczema council. J Allergy Clin Immunol. 2021;147(4):1174–1190.e1. doi:10.1016/j.jaci.2021.01.013
   PubMed Web of Science ®Google Scholar
• Hagino T, Saeki H, Fujimoto E, Kanda N. The eosinophil-to-lymphocyte ratio acts as an indicator for improvement of clinical signs and itch by upadacitinib treatment in atopic dermatitis. J Clin Med. 2023;12(6):2201. doi:10.3390/jcm12062201
   PubMed Web of Science ®Google Scholar
• Hagino T, Saeki H, Kanda N. The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan. J Dermatol. 2022;49(11):1158–1167. doi:10.1111/1346-8138.16549
   PubMed Web of Science ®Google Scholar
• Hagino T, Saeki H, Fujimoto E, Kanda N. Efficacy and safety of baricitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan. J Dermatol. 2023;50(7):869–879. doi:10.1111/1346-8138.16763
   PubMed Web of Science ®Google Scholar
• Stalder JF, Taïeb A, Atherton DJ, et al. Severity scoring of atopic dermatitis: the scorad index. consensus report of the European task force on atopic dermatitis. Dermatology. 1993;186(1):23–31.
   PubMed Web of Science ®Google Scholar
• Ständer S, Steinhoff M. Pathophysiology of pruritus in atopic dermatitis: an overview. Exp Dermatol. 2002;11(1):12–24. doi:10.1034/j.1600-0625.2002.110102.x
   PubMed Web of Science ®Google Scholar
• Reich A, Riepe C, Anastasiadou Z, et al. Itch assessment with visual analogue scale and numerical rating scale: determination of minimal clinically important difference in chronic itch. Acta Derm Venereol. 2016;96(7):978–980. doi:10.2340/00015555-2433
   PubMed Web of Science ®Google Scholar
• Legat FJ. Itch in atopic dermatitis - what is new? Front Med . 2021;8:644760. doi:10.3389/fmed.2021.644760
   Web of Science ®Google Scholar